UBS Group’s EndoChoice Holdings, Inc. GI Stock Holding History

UBS Group’s Portfolio GI Stock Details GI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,121	Closed	-$41K	–	8376
2016 Q3	$41K	Sell	5,121 -567	-10%	-$2.65K	﹤0.01%	5688
2016 Q2	$28K	Buy	5,688 +5,046	+786%	+$24.1K	﹤0.01%	6022
2016 Q1	$3K	Sell	642 -595	-48%	-$3.26K	﹤0.01%	7261
2015 Q4	$10K	Buy	1,237 +887	+253%	+$8.52K	﹤0.01%	7318
2015 Q3	$4K	Buy	+350	New	+$5.48K	﹤0.01%	7888

UBS Group's GI Position: Q4 2016 in Review

UBS Group sold out of EndoChoice Holdings, Inc. (GI) in Q4 2016, closing a stake of 5,121 shares — an estimated $41K sold.

UBS Group first reported a position in GI in Q3 2015 and held it in 5 quarters. The position peaked at $41K in Q3 2016. 0 funds tracked by Wall St. Rank hold GI as of Q4 2016.

UBS Group reported no remaining EndoChoice Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
UBS Group sold 5,121 EndoChoice Holdings, Inc. shares in Q4 2016, an estimated $41K.
UBS Group first reported a position in EndoChoice Holdings, Inc. in Q3 2015 and held it in 5 quarters.
UBS Group's EndoChoice Holdings, Inc. position peaked at $41K in Q3 2016.
0 funds tracked by Wall St. Rank held EndoChoice Holdings, Inc. as of Q4 2016.

Based on UBS Group's 13F filing for Q4 2016, filed 14 Feb 2017.